New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVAX’s income statement to Excel — free account
Novavax, Inc.
NVAXNovavax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 64.7% from fiscal 2024.
- Revenue
- −3.05%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
7.74
0.01
+0.13%
Follow NVAX
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow was −$250.2M: capital expenditures were more than operating cash flow. Cash fell by $289.2M. What is a cash flow statement?
- Free cash flow
- −$250.2M
- Returned to shareholders
- $4.8M
- Debt, net
- $32.5M borrowed
- Change in cash
- −$289.2M over the period
| Operating cash flow | −244.6 |
|---|---|
| Capital expenditures | −5.6 |
| Free cash flow | −250.2 |
| Into investments, net | −91.5 |
| Buybacks, net | −4.8 |
| Debt raised, net | +32.5 |
| Other | +24.8 |
| Change in cash | −289.2 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$259M | −$144M | −$185M | −$137M | −$43M | $323M | −$416M | −$714M | −$87M | −$245M |
| Capex | −$18M | −$4.2M | −$1.4M | $16M | −$54M | −$55M | −$89M | −$54M | $180M | −$5.6M |
| Free cash flow | −$277M | −$149M | −$186M | −$120M | −$97M | $268M | −$505M | −$768M | $92M | −$250M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
(279.97) | (183.77) | (184.75) | (132.69) | (418.26) | (1,743.75) | (657.94) | (545.06) | (187.50) | 440.30 |
Depreciation & Amortization |
9.81 | 11.24 | 9.58 | 5.68 | 4.89 | 12.66 | 29.05 | 41.23 | 48.50 | 27.61 |
Non Cash Items (Other) |
21.50 | 22.01 | 13.93 | 8.03 | 373.90 | 328.06 | 596.00 | 173.75 | 25.07 | 169.40 |
Accounts Receivable Change |
2.07 | — | — | — | (422.69) | (183.39) | 249.17 | (274.44) | 354.09 | 61.04 |
Change in inventories |
— | — | — | — | — | (8.87) | (477.80) | (74.46) | 12.91 | (3.24) |
Change in payables and accrued liability |
(4.81) | 5.19 | (6.74) | (11.48) | 163.16 | 600.33 | 913.40 | (378.80) | (385.63) | (322.57) |
Change in other assets and liabilities |
(5.96) | (1.87) | (14.40) | (12.53) | 271.55 | 1,325.56 | (1,045.91) | 350.87 | 67.11 | (622.94) |
Other operating activities |
0.66 | 2.72 | (2.45) | 6.38 | (15.08) | (7.64) | (21.90) | (7.04) | (21.81) | 5.76 |
Operating Cash Flow |
(258.77) | (144.48) | (184.82) | (136.62) | (42.54) | 322.95 | (415.94) | (713.97) | (87.26) | (244.63) |
Capital expenditures |
(18.20) | (4.19) | (1.37) | 16.48 | (54.47) | (54.50) | (89.06) | (53.77) | 179.59 | (5.56) |
Change in intangibles (net) |
— | — | — | — | (0.15) | (2.98) | (3.93) | (5.03) | (1.58) | (0.83) |
Net Aquisitions |
— | — | — | 18.33 | (165.52) | — | — | — | — | — |
Short Term Investments Change (Net) |
46.22 | 40.16 | 29.97 | 22.02 | (157.64) | 157.64 | — | — | (382.04) | (91.53) |
Other investing activities |
(39.34) | — | — | — | — | — | — | — | — | 19.65 |
Investing cash flow |
28.02 | 35.97 | 28.60 | 38.49 | (377.78) | 100.15 | (92.98) | (58.81) | (204.04) | (78.27) |
Repayment/Issuance of Debt (Net) |
314.57 | (0.04) | — | — | (96.06) | (127.91) | 76.40 | (352.34) | (3.99) | 32.54 |
Equity Repurchase (Common, Net) |
3.80 | 64.58 | 102.81 | 98.38 | 881.01 | 589.62 | 248.59 | 360.40 | 264.58 | (4.80) |
Equity Repurchase (Preffered, Net) |
— | — | — | — | 199.82 | — | — | — | — | — |
Other financial activities |
(38.52) | 26.15 | 12.91 | 14.41 | 358.82 | 320.42 | (5.26) | (3.59) | — | — |
Financing cash flow |
279.85 | 64.54 | 102.81 | 98.38 | 984.76 | 461.71 | 324.99 | 4.47 | 260.58 | 27.74 |
Exchange Rate Adjustment |
(0.33) | 0.14 | (0.05) | (0.03) | 2.12 | (5.29) | 4.52 | 3.27 | (7.80) | 5.93 |
Change in Cash |
48.76 | (43.83) | (53.47) | 0.22 | 566.56 | 879.52 | (179.41) | (765.03) | (38.52) | (289.24) |
Beginning Cash |
130.49 | 179.26 | 135.43 | 81.96 | 82.18 | 648.74 | 1,528.26 | 1,348.85 | 583.81 | 545.29 |
Ending Cash |
179.26 | 135.43 | 81.96 | 82.18 | 648.74 | 1,528.26 | 1,348.85 | 583.81 | 545.29 | 256.05 |
Stock Based Compensation |
19.16 | 19.81 | 18.31 | 17.05 | 128.04 | 183.63 | 130.30 | 85.36 | 48.15 | 36.02 |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(10.77) | 3.33 | (21.14) | (24.02) | 12.02 | 1,733.62 | (361.15) | (376.84) | 48.48 | (887.71) |
Investments Change (Net) |
46.22 | 40.16 | 29.97 | 22.02 | (157.64) | 157.64 | — | — | (382.04) | (91.53) |
Issuance/Purchase of Shares |
3.80 | 64.58 | 102.81 | 98.38 | 1,080.83 | 589.62 | 248.59 | 360.40 | 264.58 | (4.80) |
| Other line items | ||||||||||
Revenue per Employee |
0.04 | 0.09 | 0.09 | 0.11 | 0.60 | 0.74 | 0.99 | 0.64 | 0.72 | 1.50 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026